IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v20y2023i5p3825-d1075622.html
   My bibliography  Save this article

Impact of COVID-19 Pandemic on Adherence to Chronic Therapies: A Systematic Review

Author

Listed:
  • Elena Olmastroni

    (Epidemiology and Preventive Pharmacology Service (SEFAP), Department of Pharmacological and Biomolecular Sciences, University of Milan, 20133 Milan, Italy)

  • Federica Galimberti

    (IRCCS MultiMedica, 20099 Sesto San Giovanni (MI), Italy)

  • Elena Tragni

    (Epidemiology and Preventive Pharmacology Service (SEFAP), Department of Pharmacological and Biomolecular Sciences, University of Milan, 20133 Milan, Italy)

  • Alberico L. Catapano

    (Epidemiology and Preventive Pharmacology Service (SEFAP), Department of Pharmacological and Biomolecular Sciences, University of Milan, 20133 Milan, Italy
    IRCCS MultiMedica, 20099 Sesto San Giovanni (MI), Italy)

  • Manuela Casula

    (Epidemiology and Preventive Pharmacology Service (SEFAP), Department of Pharmacological and Biomolecular Sciences, University of Milan, 20133 Milan, Italy
    IRCCS MultiMedica, 20099 Sesto San Giovanni (MI), Italy)

Abstract

The spread of the coronavirus disease 2019 (COVID-19) pandemic caused a sudden and significant disruption in healthcare services, especially for patients suffering from chronic diseases. We aimed at evaluating the impact of the pandemic on adherence to chronic therapies through a systematic review of available studies. PubMed, EMBASE, and Web of Science were searched since inception to June 2022. Inclusion criteria were: (1) observational studies or surveys; (2) studies on patients with chronic diseases; (3) reporting the effects of COVID-19 pandemic on adherence to chronic pharmacological treatment, as a comparison of adherence during the pandemic period vs. pre-pandemic period (primary outcome) or as rate of treatment discontinuation/delay specifically due to factors linked to COVID-19 (secondary outcome). Findings from 12 (primary outcome) and 24 (secondary outcome) studies showed that many chronic treatments were interrupted or affected by a reduced adherence in the pandemic period, and that fear of infection, difficulty in reaching physicians or healthcare facilities, and unavailability of medication were often reported as reasons for discontinuation or modification of chronic therapies. For other therapies where the patient was not required to attend the clinic, continuity of treatment was sometimes ensured through the use of telemedicine, and the adherence was guaranteed with drug stockpiling. While the effects of the possible worsening of chronic disease management need to be monitored over time, positive strategies should be acknowledged, such as the implementation of e-health tools and the expanded role of community pharmacists, and may play an important role in preserving continuity of care for people with chronic diseases.

Suggested Citation

  • Elena Olmastroni & Federica Galimberti & Elena Tragni & Alberico L. Catapano & Manuela Casula, 2023. "Impact of COVID-19 Pandemic on Adherence to Chronic Therapies: A Systematic Review," IJERPH, MDPI, vol. 20(5), pages 1-15, February.
    • Handle: RePEc:gam:jijerp:v:20:y:2023:i:5:p:3825-:d:1075622
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/20/5/3825/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/20/5/3825/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Manuela Casula & Federica Galimberti & Marica Iommi & Elena Olmastroni & Simona Rosa & Mattia Altini & Alberico L. Catapano & Elena Tragni & Elisabetta Poluzzi, 2022. "Impact of the COVID-19 Pandemic on the Therapeutic Continuity among Outpatients with Chronic Cardiovascular Therapies," IJERPH, MDPI, vol. 19(19), pages 1-11, September.
    2. Jeffrey Clement & Maura Jacobi & Brad N Greenwood, 2021. "Patient access to chronic medications during the Covid-19 pandemic: Evidence from a comprehensive dataset of US insurance claims," PLOS ONE, Public Library of Science, vol. 16(4), pages 1-13, April.
    3. Luís Midão & Marta Almada & Joana Carrilho & Rute Sampaio & Elísio Costa, 2022. "Pharmacological Adherence Behavior Changes during COVID-19 Outbreak in a Portugal Patient Cohort," IJERPH, MDPI, vol. 19(3), pages 1-12, January.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Di Novi, Cinzia & Leporatti, Lucia & Levaggi, Rosella & Montefiori, Marcello, 2022. "Adherence during COVID-19: The role of aging and socio-economics status in shaping drug utilization," Journal of Economic Behavior & Organization, Elsevier, vol. 204(C), pages 1-14.
    2. Péter Elek & Anikó Bíró & Petra Fadgyas‐Freyler, 2021. "Income gradient of pharmaceutical panic buying at the outbreak of the COVID‐19 pandemic," Health Economics, John Wiley & Sons, Ltd., vol. 30(9), pages 2312-2320, September.
    3. Manuela Casula & Federica Galimberti & Marica Iommi & Elena Olmastroni & Simona Rosa & Mattia Altini & Alberico L. Catapano & Elena Tragni & Elisabetta Poluzzi, 2022. "Impact of the COVID-19 Pandemic on the Therapeutic Continuity among Outpatients with Chronic Cardiovascular Therapies," IJERPH, MDPI, vol. 19(19), pages 1-11, September.
    4. Cronin, Christopher J. & Evans, William N., 2022. "Nursing home quality, COVID-19 deaths, and excess mortality," Journal of Health Economics, Elsevier, vol. 82(C).
    5. Ecaterina Coman & Claudiu Coman & Angela Repanovici & Mihaela Baritz & Attila Kovacs & Ana Maria Tomozeiu & Silviu Barbu & Ovidiu Toderici, 2022. "Does Sustainable Consumption Matter? The Influence of the COVID-19 Pandemic on Medication Use in Brasov, Romania," Sustainability, MDPI, vol. 14(13), pages 1-16, June.
    6. Michał Święczkowski & Sławomir Dobrzycki & Łukasz Kuźma, 2023. "Multi-City Analysis of the Acute Effect of Polish Smog on Cause-Specific Mortality (EP-PARTICLES Study)," IJERPH, MDPI, vol. 20(8), pages 1-17, April.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:20:y:2023:i:5:p:3825-:d:1075622. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.